Center for Medical Genetics, Faculty of Medicine and Health Sciences, Antwerp University Hospital/University of Antwerp, Prins Boudewijnlaan 43, 2650, Antwerp, Belgium.
Adv Exp Med Biol. 2014;802:95-105. doi: 10.1007/978-94-007-7893-1_7.
Loeys-Dietz syndrome is an autosomal dominant aortic aneurysm syndrome characterized by multisystemic involvement. The most typical clinical triad includes hypertelorism, bifid uvula or cleft palate and aortic aneurysm with tortuosity. Natural history is significant for aortic dissection at smaller aortic diameter and arterial aneurysms throughout the arterial tree. The genetic cause is heterogeneous and includes mutations in genes encoding for components of the transforming growth factor beta (TGFβ) signalling pathway: TGFBR1, TGFBR2, SMAD3 and TGFB2. Despite the loss of function nature of these mutations, the patient-derived aortic tissues show evidence of increased (rather than decreased) TGFβ signalling. These insights offer new options for therapeutic interventions.
Loeys-Dietz 综合征是一种常染色体显性遗传的主动脉瘤综合征,其特征为多系统受累。最典型的三联征包括眼距过宽、悬雍垂分裂或腭裂以及主动脉瘤伴扭曲。其自然病史表现为在较小的主动脉直径和整个动脉树的动脉瘤处发生主动脉夹层。遗传原因是异质性的,包括编码转化生长因子β(TGFβ)信号通路成分的基因突变:TGFBR1、TGFBR2、SMAD3 和 TGFB2。尽管这些突变具有功能丧失的性质,但患者来源的主动脉组织显示出 TGFβ 信号增加(而不是减少)的证据。这些见解为治疗干预提供了新的选择。